Pure Global

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops - Trial NCT06209320

Access comprehensive clinical trial information for NCT06209320 through Pure Global AI's free database. This Phase 3 trial is sponsored by Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. and is currently Recruitment Completed. The study focuses on Myopia. Target enrollment is 777 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06209320
Phase 3
Recruitment Completed
drug
Trial Details
ClinicalTrials.gov • NCT06209320
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in Children

Study Focus

Myopia

Lower dose atropine sulfate eye drops

Interventional

drug

Sponsor & Location

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Beijing, China

Timeline & Enrollment

Phase 3

Mar 15, 2022

Aug 01, 2025

777 participants

Primary Outcome

Cycloplegic Autorefraction(SER)

Summary

A randomized, double-blind, placebo-controlled, multicenter, phase III clinical study of the
 efficacy and safety of two low-concentration atropine sulfate eye drops in slowing the
 progression of myopia in children

ICD-10 Classifications

Myopia
Degenerative myopia
Amblyopia ex anopsia
Ocular myiasis
Myiasis

Data Source

ClinicalTrials.gov

NCT06209320

Non-Device Trial